Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy

BACKGROUND/AIMS: To evaluate the impact of isoniazid (INH) treatment for latent tuberculosis infection (LTBI) on the development of liver function test (LFT) abnormality and the persistence of tumor necrosis factor (TNF) inhibitors in rheumatoid arthritis (RA) patients. METHODS: We retrospectively e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Korean J Intern Med
Autores principales: Sung, Yoon-Kyoung, Cho, Soo-Kyung, Kim, Dam, Won, Soyoung, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Yoo, Dae-Hyun, Bae, Sang-Cheol
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129622/
https://ncbi.nlm.nih.gov/pubmed/28288508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.214
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares